On October 3, 2022, Aktiv Pharma Group (Aktiv) announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services
Todd Research, a global expert in threat detection X-ray equipment for safety and security, is delighted to have been honoured with a Queen’s Award for Enterprise: Innovation 2022 for its outstanding TR15 and TR40 cabinet X-ray scanners. This prestigious award recognises Todd Research’s ongoing
AirBoss of America Corp. announced on October 5th that AirBoss Defense Group ("ADG") has recently been awarded an additional US$22.0 million in contracts across its survivability portfolio for multiple parties in North America and internationally.
INOVIO today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA® 3PSP smart device and the procurement of CELLECTRA® 2000 devices, which are
On November 20, 2019, American Security Today (AST) announced the 2019 ‘ASTORS’ Homeland Security Award’ winners for outstanding product development and innovative technologies that are mission-ready for critical security applications. We’re proud to report the FLIR MUVE™ C360 won a Platinum
Dr Arnab Basu, chief executive at Kromek Group, picked up the Innovation accolade at the national final of the Institute of Directors’ (IoD) Director of the Year Awards. His triumph follows success in the same category at the IoD’s Yorkshire and North East heat earlier this year.
The U.S. Department of Health and Human Services (HHS) will support tests of organ-on-a-chip technology to determine how it can be used to understand injuries caused by inhaled chlorine gas, a potential national security threat, and to develop treatments for those injuries.
Block MEMS, a leading developer of Quantum Cascade Laser (QCL) based infrared detection systems, has been awarded a $3.5M contract from the Defense Advanced Research Agency (DARPA), as part of the SIGMA+ Program. The goal of the program is to develop a persistent, real-time, early detection
Myelo Therapeutics GmbH, an Affiliate of Eckert & Ziegler Strahlen- und Medizintechnik AG, has announced that the European Medicines Agency (EMA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 (Imidazolyl ethanamide pentandioic acid) for